One page, thousands of outlets. See who else covered it.
Celcuity has provided further details on why the commercial rollout of its recently approved cancer drug is slower than investors initially anticipated. The drugmaker said it is waiting for the FDA to review a second ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Ghana's Food and Drugs Authority (FDA) warns consumers against purchasing flood-damaged food and drinks following recent flooding.
Discover 8 biotech companies in Melbourne, ranging from commercial to preclinical-stage companies, advancing promising technologies.
Augustė Užuotaitė of Thermo Fisher Scientific feels the real innovation ahead is not just smarter software or technology.
Picture a driver approaching a sharp bend on a country road. As the car turns, they move their foot to slow down. But instead of pressing the brake, they hit the accelerator. The car surges forward.
AstraZeneca is discontinuing a late-stage drug trial in patients with metastatic non-small cell lung cancer, extending a run of setbacks